Category Archives: Drug Side Effects

Los Angeles, CA (PRWEB) June 12, 2013 The diabetes drug safety advocates at DrugRisk.com are announcing new information on the site for those patients taking the medications Januvia or Janumet. A university head of endocrinology and former editor of the American Diabetes Association journal has advised the drug may be connected to pancreatic cancer*. DrugRisk was created to improve patient safety by providing the latest warnings, recalls, studies and legal news for popular drugs like Januvia and Janumet. Visitors can see if others are experiencing similar side effects and decide if they need legal advice. Januvia and Janumet are pill-form diabetes medications prescribed to help those with type-2 diabetes control blood sugar. The drugs were two of the best-selling for Merck in recent years, with sales of over $4 billion last year**. The resource center contains studies suggesting Januvia and Janumet may be linked to cancer. A 2011 study from UCLA indicated the drug could increase the risk of pancreatic cancer by 172% and thyroid cancer by 48%***. The FDA is also investigating the risk of Janumet and Januvia cancer after receiving reports that some patients who died showed signs of early pancreatic cancer cells****. Now, DrugRisk has learned that … Continue reading →

by Bert B. Sulat Jr. Posted on 06/11/2013 2:17 PM |Updated 06/11/2013 2:34 PM GOOD GIRLS GONE... Catherine Zeta-Jones (right) and Rooney Mara play shadowy figures in 'Side Effects.' All photos from the Side Effects Movie Facebook page MANILA, Philippines - The interesting Side Effects comes to theaters with some interesting, real-life trivia. For one thing, this will be the last big-screen movie from American director Steven Soderbergh in a long while, if not for good. This is due in part to his difficult experience in getting financing for his newer, biographical Liberace film Behind the Candelabra (which wound up being financed by HBO and is thus a cable TV release). Side Effects also features a fictitious drug for manic depressives or those with bipolar disorder the latter a condition that does afflict one of the films cast members, Catherine Zeta-Jones. And one of the movies lead characters gets mired in a sensational, paparazzi-luring controversy and the character is portrayed by sometime tabloid pet, Jude Law. Yet Soderbergh, who had helmed hits such as his Oceans trilogy, Out of Sight, Erin Brokovich and Magic Mike as well the lesser-known likes of The Limey, Solaris and The Girlfriend Experience, is not … Continue reading →

Love and Other Drugs already expostulated with definitive, exhaustive authority on the small-scale effects of maintenance pills on long-time Parkinsons sufferers and its potential for comedy, relationship drama, and the medical rep trade. Good thing director Steven Soderbergh takes a completely different, serious tack with Side Effects. Revealing any of the twists (at least the two major ones) would completely ruin the experience of this whodunit of a thriller for you, so well keep this review to the bare bones. This movie gleefully dives into the ramifications of pharmaceutical treatment for psychological ills, specifically on anti-depressant drugs. We begin with Emily Taylor (Rooney Mara), who is one truly depressed woman. Her husband, Martin (Channing Tatum), has just been released from prison after serving four years for insider trading. He would have gotten away clean but, like many financial guys on the up and up, he got greedy and he got sloppy. So, he got caught. While Emily and Martins mom are amped that hes out of the big house, the family is still at ground zero when it comes to money. While she claims theres no connection to their financial woes, Emily shortly afterwards drives her car right smack into … Continue reading →

Chicago, IL (PRWEB) June 10, 2013 The prescription drug safety advocates at DrugRisk.com are alerting patients taking the blood thinner Pradaxa of updated information on the site. As the number of injury claims grows*****, a new study warns that patients may not be taking the drug correctly and there may be an added risk when switching from other blood thinners*. DrugRisk was created to improve the safety of patients taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice. Pradaxa was launched in 2010 to prevent strokes in patients with atrial fibrillation. Experts disagree, however, about whether it carries higher risks for internal bleeding. The FDA recently advised that Pradaxa is no more dangerous than traditional blood thinner warfarin**. However, DrugRisk contains information from the Institute for Safe Medication Practices, who warned that patients suffering Pradaxa bleeding are nearly 5 times as likely to die than those with bleeding from Coumadin or warfarin. They also named anticoagulants like Pradaxa among the most dangerous drugs available***. The resource center also contains research from the University of Illinois at Chicago suggesting … Continue reading →

Chicago, IL (PRWEB) June 08, 2013 The birth control information center at DrugRisk.com is announcing new information on the site for women who have taken the contraceptives Yaz or Yasmin. Records show the number of pending cases filed alleging blood clots has decreased as Bayer reserves compensation for victims*. DrugRisk was created to improve the safety of patients taking popular prescription drugs like Yaz and Yasmin, by providing the latest research, safety alerts, recalls and litigation news. Visitors can determine if others have experienced similar side effects and decide if they need legal advice. The resource center has added warnings from health experts like the British Medical Journal** and FDA*** that birth control pills containing the hormone drospirenone, such as Yaz and Yasmin, can increase the risk of blood clots. Due to the number of patients that have filed a Yaz lawsuit alleging blood clots, cases were consolidated to a special federal Multi-District Litigation court in Illinois (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)). DrugRisk has learned that Bayer has spent nearly $1 billion so far to settle around 4,800 Yaz lawsuits alleging blood clot injuries like pulmonary embolism or … Continue reading →

New York, NY (PRWEB) June 07, 2013 The birth control safety advocates at DrugRisk.com are announcing new information on the site for women using the IUD contraceptive Mirena. The New Jersey Supreme Court recently added a multidistrict court for Mirena claims in that state to join a federal MDL created last month*. The goal of DrugRisk is to improve the safety of patients using popular medication devices like IUDs by providing the latest safety alerts, recalls, studies and legal news. Visitors can determine if others are experiencing similar side effects and decide if they need legal advice. The resource center has added warnings from health experts about the risk of perforation from IUDs such as Mirena. The FDA has warned that the procedure of inserting the Mirena IUD can result in perforation of reproductive organs**. DrugRisk also contains a study published by the Journal of the Society of Laparoendoscopic Surgeons, which warns patients that Mirena IUDs can become dislodged and perforate the uterine wall after they are implanted***. With a growing number of patients filing a Mirena lawsuit, federal cases have been consolidated to a special multi-district litigation court in the Southern District of New York (In Re: Mirena IUD … Continue reading →

Los Angeles, CA (PRWEB) June 06, 2013 The diabetes drug safety center at DrugRisk.com is announcing updated information for patients taking the medication Byetta. A university head of endocrinology and former editor of the American Diabetes Association journal has advised the drug may be connected to pancreatic cancer*. DrugRisk was created to improve the safety of patients taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice. Byetta is a twice-daily injectable medication released in 2005 to help those with type-2 diabetes control blood sugar. Last year the drug had sales of over $300 million, when it was acquired by Bristol-Myers Squibb**. The resource center added a 2011 study from the University of California at Los Angeles, indicating Byetta could increase the risk of pancreatic cancer by 290% and thyroid cancer by 473%***. Now, DrugRisk has learned that the lead researcher of that study, head of endocrinology at UCLA Dr. Peter Butler, worries that the risk was not detected in trials prior to FDA approval because the manufacturer used very young animals not as prone to pancreatic cancer*. The … Continue reading →

Contributor (866) 529-2400 Faced with the 2013 onset of generic competition against its male pattern hair loss drug, Propecia (finasteride), Merck has experienced diminishing dollars while it has tried to make sense of the hundreds of Propecia lawsuits filed by men (and some spouses) who have suffered enduring erectile problems and related side effects since using the drug. Before the loss of market exclusivity became an issue, Merck saw its Propecia sales stagnate at $447 million in 2010 and 2011 and then decline to $424 million in 2012. As the Propecia patent has approached its October 2013 sunset, one generic competitor already has been allowed into the market in January and another will get the green light in July. Propecia sales in the first quarter of 2013 were down 37 percent to $68 million compared to the same period in 2012. The plaintiffs have shed no tears over Mercks Propecia sales losses. Realizing that their health suffered from an increased risk of severe Propecia side effects, about which the manufacturer should have known and warned about, these victims have hired counsel and have pursued recoverable damages. Actually, there are two Merck drugs involved in this sort of litigation. Proscar is … Continue reading →

London, June 3 (ANI): A new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer. The results were presented at the 2013 meeting of the American Society of Clinical Oncology today in Chicago by Dr. Antoni Ribas, professor of medicine in the UCLA division of hematology-oncology, who led the research. The results are from the first clinical trial of the drug lambrolizumab (MK3475), which was discovered and developed by Merck. Researchers analyzed 135 patients with advanced metastatic melanoma who were divided into three groups with different treatment regimens. Overall, 38 percent of patients taking lambrolizumab saw confirmed improvement of their cancer across all dose levels. Of those taking the lowest dose of lambrolizumab, 25 percent showed improvement, while 52 percent of those who received the highest dose improved. The rate of any tumor response across all patients was 77 percent. Researchers have not yet determined the average duration of response to the drug, because only five patients who had initial responses were taken off the study after their cancers got worse. To date, the longest response has been over one year. Side effects with lambrolizumab … Continue reading →

Alli Diet Pills For Sale Uk 😎 Best Weight Loss Pills Over the Counter Get FDA Approved Alli Diet Pills For Sale Uk #-o http://tinyurl.com/proven-unique-weight-loss Will you be a person that is not wanting to enroll in a health club membership? ... By: Pedro Gavino … Continue reading →